Wilbur Gantz is the President of PathoCapital, LLC, a privately owned company investing in the healthcare field. He is Chairman of Aptinyx, Inc. a biotech company developing drugs for CNS indications.
Mr. Gantz has been on the boards of the Gillette Company Gambro, A.B., Baxter International, Inc., W.W. Grainger, Inc. and the Chair of Harris Financial Corporation. He has served in leadership positions in Baxter Healthcare, Pathogenesis, Ovation Pharmaceuticals, and Naurex. He is the Chairman elect of the Board of Trustees of the Field Museum of Natural History and a former Trustee of Princeton University.